Imunon, Inc. Entity Listing, Par Value Per Share
Imunon, Inc. (IMNN) reported Entity Listing, Par Value Per Share of $0.01 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityListingParValuePerShare · last filed 2026-08-11
- Imunon, Inc. entity listing, par value per share for the quarter ending 2026-03-31 was $0.01, a 0.00% change year-over-year.
- Imunon, Inc. entity listing, par value per share for the quarter ending 2025-03-31 was $0.01.
| Period end | Entity Listing, Par Value Per Share 3 month | Entity Listing, Par Value Per Share 6 month | Entity Listing, Par Value Per Share 9 month |
|---|---|---|---|
| 2026-06-30 | $0.01 10-Q · filed 2026-08-11 | ||
| 2026-03-31 | $0.01 10-Q · filed 2026-05-12 | ||
| 2025-09-30 | $0.01 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $0.01 10-Q · filed 2025-08-05 | ||
| 2025-03-31 | $0.01 10-Q · filed 2025-05-12 | ||
| 2024-09-30 | $0.01 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | $0.01 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |